American Society of Hirudotherapy

Replantation of pediatric scalp avulsions

Case series published in J Craniofac Surg (2022)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportClinical TrialsGur et al. · The Journal of craniofacial surgery, 2022

Abstract

Scalp avulsions are rare but can be quite morbid clinical manifestations. Pediatric patients are different from adults as they have not completed their physical, sexual, educational, or psychosocial development. Therefore, the devastation of a failed scalp replantation is much greater on these individuals, their whole future lives, and families. We present 2 consecutive pediatric cases retrospectively with the youngest successful replanted patient in Turkey and describe technical tips according to our experience.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAdultHumansChildScalpRetrospective StudiesMicrosurgeryAnastomosis, SurgicalAmputation, Traumatic

Summary

Pediatric scalp avulsion replantation case series with microsurgical technique considerations.

Why This Matters for Hirudotherapy

This retrospective article presents two consecutive pediatric scalp avulsion cases managed with replantation, including the youngest successfully replanted patient in Turkey, with technical tips based on the authors' experience. The abstract emphasizes differences between pediatric and adult patients and the heightened psychosocial stakes of failed replantation in children. There is no mention of leeches, hirudotherapy, hirudin, or any leech-derived substance in the abstract. Although leech therapy can be used adjunctively in replantation surgery, this article does not document such use. The article has no direct relevance to ASH's research domain.

Citation

Replantation of pediatric scalp avulsions.

Gur et al. · The Journal of craniofacial surgery, 2022

Added to ASH library: May 27, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.